Unusual Clinical Presentation of Carcinoma
935
291. Papakonstantinou K, Antoniou A, Palialexis K, et al. Fallopian
tube cancer presenting as inflammatory breast carcinoma: re
port of a case and review of the literature.
Eur J Gynaecol Oncol
2009;30:568–571.
Recurrent Carcinoma in Transverse Rectus Abdominis
Myocutaneous (TRAM) Flap
292. Alderman AK, McMahon L Jr, Wilkins EG. The national utilization
of immediate and early delayed breast reconstruction and the effect of
sociodemographic factors.
Plast Reconstr Surg
2003;111:695–703.
293. Hartrampf CR, Cheflan M, Black PW. Breast reconstruction with a
transverse abdominal island flap.
Plast Reconstr Surg
1982;69:216–224.
294. Singletary SE. Skin-sparring mastectomy with immediate breast re
construction in the M.D. Anderson Cancer Center experience.
Ann
Surg Oncol
1996;3:411–416.
295. Slavin SA, Love SM, Goldwyn RM. Recurrent breast cancer follow
ing immediate reconstruction with myocutaneous flaps.
Plast Reconstr
Surg
1994;93:1191–1204.
296. Howard MA, Polo K, Pusic AL, et al. Breast cancer local recurrence
after mastectomy and TRAM flap reconstruction: incidence and treat
ment options.
Plast Reconstr Surg
2006;117:1381–1386.
297. Shaikh N, LaTrenta G, Swistel A, et al. Detection of recurrent
breast cancer after TRAM flap reconstruction.
Ann Plast Surg
2001;47:602–607.
298. Chung SM, Shin SJ, Chen X, et al. Recurrent breast carcinoma arising
in a transverse rectus abdominis myocutaneous flap.
Arch Pathol Lab
Med
2004;128:1157–1160.
299. Helvie MA, Bailey JE, Roubidoux MA, et al. Mammographic screen
ing of TRAM flap breast reconstructions for detection of nonpalpable
recurrent cancer.
Radiology
2002;224:211–216.
300. Mund DF, Wolfson P, Corczyca DP, et al. Mammographically de
tected recurrent nonpalpable carcinoma developing in a trans
verse rectus abdominis myocutaneous flap: a case report.
Cancer
1994;74:2804–2807.
301. Hsu W, Sheen-Chen SM, Eng HL, et al. Mammographic microcalci
fication in an autogenously reconstructed breast simulating recurrent
carcinoma.
Tumori
2008;94:574–576.
302. Franceschini G, Salgarello M, Masetti R, et al. A giant papillary car
cinoma of the breast treated with mastectomy and bipedicled TRAM
flap.
Ann Ital Chir
2006;77:341–344.
303. Kobraei EM, Kenady DE, Rogers WB III, et al. Cancer recurrence in
volving a TRAM flap and abdominal donor site following mastectomy
and immediate breast reconstruction: a case report.
Ann Plast Surg
2012;68:559–561.
304. Huang CJ, Hou MF, Lin SD, et al. Comparison of local recurrence
and distant metastases between breast cancer patients after postmas
tectomy radiotherapy with and without immediate TRAM flap recon
struction.
Plast Reconstr Surg
2006;118:1079–1086.
305. Hanasono MM, Osborne MP, Dielubanza EJ, et al. Radiation-induced
angiosarcoma after mastectomy and TRAM flap breast reconstruc
tion.
Ann Plast Surg
2005;54:211–214.
306. Olcina M, Merck B, Giménez-Climent MJ, et al. Radiation-induced
leiomyosarcoma after breast cancer treatment and TRAM flap recon
struction.
Sarcoma
2008;2008:456950.
307. Casey WJ III, Rebecca AM, Silverman A, et al. Etiology of breast
masses after autologous breast reconstruction.
Ann Surg Oncol
2013;20:607–614.
271. Dawood S, Merajver SD, Viens P, et al. International expert panel on
inflammatory breast cancer: consensus statement for standardized di
agnosis and treatment.
Ann Oncol
2011;22:515–523.
272. Overmoyer BA, Lee JM, Lerwill MF. Case records of the Massachusetts
General Hospital. Case 17-2011. A49-year-oldwomanwith amass in the
breast and overlying skin changes.
N Engl J Med
2011;364:2246–2254.
273. Fastenberg NA, Buzdar AV, Montague ED, et al. Management of in
flammatory carcinoma of the breast. A combined modality approach.
Am J Clin Oncol
1985;8:134–141.
274. McBrideCM,HortobagyiGN.Primaryinflammatorycarcinomaofthefe
male breast: staging and treatment possibilities.
Surgery
1985;98:792–798.
275. Moore MP, Ihde JK, Crowe JP Jr, et al. Inflammatory breast cancer.
Arch Surg
1991;126:304–306.
276. Palangie T, Mosseri V, Mihura J, et al. Prognostic factors in inflam
matory breast cancer and therapeutic implications.
Eur J Cancer
1994;30A:921–927.
277. Brun B, Otmezguine Y, Feuilhade F, et al. Treatment of inflammatory
breast cancer with combination chemotherapy and mastectomy ver
sus breast conservation.
Cancer
1988;61:1096–1103.
278. Chevallier B, Asselain B, Kunlin A, et al. Inflammatory breast cancer.
Determination of prognostic factors by univariate and multivariate
analysis.
Cancer
1987;60:897–902.
279. Jaiyesimi IA, Buzdar AU, Hortobagyi G. Inflammatory breast cancer:
a review.
J Clin Oncol
1992;10:1014–1024.
280. Knight CD Jr, Martin JK Jr, Welch JS, et al. Surgical considerations
after radiation therapy for inflammatory breast cancer.
Surgery
1986;99:385–391.
281. Picciocchi A, Masetti R, Terribile D, et al. Inflammatory breast car
cinoma: contribution of surgery as part of a combined modality ap
proach.
Breast Dis
1994;7:143–149.
282. Carlson RW, Favret AM. Multidisciplinary management of locally ad
vanced breast cancer.
Breast J
1999;5:303–307.
283. Crowe J, Hakes T, Rosen PP, et al. Changing trends in the manage
ment of inflammatory breast cancer: a clinical-pathological review of
69 patients.
Am J Clin Oncol
1985;8:21.
284. Feldman LD, Hortobagyi GN, Buzdar AW, et al. Pathological assess
ment of response to induction chemotherapy in breast cancer.
Cancer
Res
1986;46:2578–2581.
285. McCready DR, Hortobagyi GN, Kau SW, et al. The prognostic signifi
cance of lymph node metastases after preoperative chemotherapy for
locally advanced breast cancer.
Arch Surg
1989;124:21–25.
286. Hennessy BT, Gonzalez-Angulo AM, Hortobagyi GN, et al. Disease-
free and overall survival after pathologic complete disease remis
sion of cytologically proven inflammatory breast carcinoma axillary
lymph node metastases after primary systemic chemotherapy.
Cancer
2006;106:1000–1006.
287. Hennessy BT, Hortobagyi GN, Rouzier R, et al. Outcome after
pathologic complete eradication of cytologically proven breast can
cer axillary node metastases following chemotherapy.
J Clin Oncol
2005;23:9304–9311.
288. Rehman S, Reddy CA, Tendulkar RD. Modern outcomes of inflamma
tory breast cancer.
Int J Radiat Oncol Biol Phys
2012;84:619–624.
289. Krishnan C, Moline S, Anders K, et al. Intravascular ALK positive
anaplastic large-cell lymphoma mimicking inflammatory breast car
cinoma.
J Clin Oncol
2009;27:2563–2565
290. Khalifeh I, Deavers MT, Cristofanilli M, et al. Primary peritoneal se
rous carcinoma presenting as inflammatory breast cancer.
Breast J
2009;15:176–181.
